Prognosis for patients with ICD 10 CM code c75.1 and evidence-based practice

ICD-10-CM Code C75.1: Malignant Neoplasm of Pituitary Gland

This code falls under the broader category of Neoplasms > Malignant neoplasms, signifying a cancer of the pituitary gland, a crucial endocrine gland located at the base of the brain. Often referred to as the “master gland,” the pituitary regulates the activity of other endocrine glands, including the thyroid, adrenal glands, ovaries, and testes.

Exclusions:

It's important to note that code C75.1 does not apply to:

Malignant carcinoid tumors (C7A.0-), a category that encompasses neuroendocrine tumors originating from neuroendocrine cells, commonly found in the gastrointestinal tract. Malignant neoplasm of the adrenal gland (C74.-), covering cancers impacting the adrenal glands located on top of the kidneys. Malignant neoplasm of the endocrine pancreas (C25.4), which specifically designates cancers originating in the pancreas, particularly those involving the islet cells, responsible for hormone production. Malignant neoplasm of the islets of Langerhans (C25.4), a code used for cancers directly affecting the islets of Langerhans, cells within the pancreas responsible for insulin and other hormone production. Malignant neoplasm of the ovary (C56.-), which categorizes cancers occurring in the female reproductive organs known as ovaries. Malignant neoplasm of the testis (C62.-), indicating cancer of the male reproductive organs, specifically the testicles. Malignant neoplasm of the thymus (C37), encompassing cancers arising in the thymus gland, a small organ located in the chest that plays a critical role in the development of immune cells. Malignant neoplasm of the thyroid gland (C73), a code covering cancers originating in the thyroid gland, positioned in the neck and vital for hormone regulation. Malignant neuroendocrine tumors (C7A.-), a category that includes malignant tumors originating from neuroendocrine cells across various body locations, with the exception of those specified in C75.1.

Related Symbols:

The code is marked with a colon symbol ":", indicating its applicability as a “complication or comorbidity.” This signifies that C75.1 can be included as an additional code in a patient’s medical record, even if it’s not the primary reason for the encounter, as long as the condition influences the course of treatment or the patient's overall healthcare.

Clinical Implications:

A malignant neoplasm of the pituitary gland is a rare form of cancer. It can lead to altered levels of pituitary hormones, either decreased or increased, resulting in a wide spectrum of symptoms.

Common Symptoms:

Headaches Vision problems Hormonal imbalances, potentially leading to: Growth problems Menstrual irregularities Infertility Fatigue and weakness Mood changes High blood pressure Weight gain or loss Elevated blood glucose levels

Diagnostic Testing:

History and Physical Exam Blood and urine tests to assess hormone levels Pituitary gland biopsy Imaging tests: Computed tomography (CT) scans Magnetic resonance imaging (MRI) scans

Treatment Options:

Surgery to remove the tumor or pituitary gland Stereotactic radiosurgery or other radiation therapy Medications: Hormone replacement therapy Drugs to block hormone production

Reporting:

This code is generally reported in conjunction with:

ICD-10-CM codes for the specific hormonal imbalances or symptoms a patient experiences, which can include: E24.0 Diabetes insipidus E24.1 Syndrome of inappropriate antidiuretic hormone secretion E24.4 Hypopituitarism E24.5 Pituitary dwarfism E24.8 Other disorders of pituitary function CPT codes for the procedures used to diagnose and treat the cancer, such as: 61545 Craniotomy with elevation of bone flap; for excision of craniopharyngioma 61546 Craniotomy for hypophysectomy or excision of pituitary tumor, intracranial approach 61548 Hypophysectomy or excision of pituitary tumor, transnasal or transseptal approach, nonstereotactic 61796 Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion HCPCS codes for supplies or procedures: C1772 Infusion pump, programmable (implantable) C8957 Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump S5502 Home infusion therapy, catheter care/maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem DRG codes: 643 Endocrine Disorders with MCC 644 Endocrine Disorders with CC 645 Endocrine Disorders without CC/MCC

Examples:

Example 1: A patient presents to the emergency department experiencing a sudden onset of severe headaches and blurry vision. Following a thorough examination, including an MRI of the brain and a pituitary gland biopsy, a malignant neoplasm of the pituitary gland is diagnosed. C75.1 is reported in conjunction with E24.4 (hypopituitarism), reflecting the potential hormonal imbalances associated with this condition.

Example 2: A patient with a known history of a malignant neoplasm of the pituitary gland visits a clinic for follow-up care after undergoing surgery. They express fatigue and report ongoing hormonal irregularities. C75.1 is reported along with E24.5 (pituitary dwarfism) to reflect the persistent health issues arising from the underlying cancer.

Example 3: A patient receives stereotactic radiosurgery to address a malignant neoplasm of the pituitary gland. C75.1 is reported alongside 61796 (Stereotactic radiosurgery (particle beam, gamma ray, or linear accelerator); 1 simple cranial lesion) to accurately identify the procedure performed.